Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Commentary
Nature Nanotechnology 3, 242–244 (1 May 2008) | doi:10.1038/nnano.2008.114
Seven challenges for nanomedicine
&
Abstract
The marriage of nanotechnology and medicine has yielded an offspring that is set to bring momentous advances in the fight against a range of diseases. Nanomedicine is actually a child well past its infancy, with two families of therapeutic nanocarriers — liposomes and albumin nanoparticles — firmly in clinical practice worldwide, a dozen or so therapeutic agents in clinical trials, and still more in the preclinical phases of development.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
